{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T22:21:40Z","timestamp":1762035700338,"version":"build-2065373602"},"reference-count":19,"publisher":"SLACK, Inc.","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pediatr Ophthalmol Strabismus"],"published-print":{"date-parts":[[1997,9]]},"abstract":"<jats:p>ABSTRACT<\/jats:p>\n          <jats:p>Objective: To determine the effects of surfactant on retinopathy of prematurity (ROP).<\/jats:p>\n          <jats:p>Design: YJe compared infants for VA years both before and after the introduction of surfactant in our neonatal intensive care unit (NICU) using prospectively collected data. Exogenous surfactant (Exosurf) was introduced into our NICU on July 1, 1991.<\/jats:p>\n          <jats:p>Methods: We compared the incidence and severity of ROP in two groups of infants born at less than 29 weeks' gestation who required cryo- or laser therapy. Premature infants born during the first 3% years following the introduction of surfactant were compared with those born during the 31\/2-year period prior to its introduction. The infants were examined by one ophthalmologist (J.K.) and classified according to the International Classification of ROP.<\/jats:p>\n          <jats:p>Results: A total of 124 infants born presurfactant and 152 infants born postsurfactant were examined for the presence of ROP. No significant difference between the two groups regarding any stage of ROP or the necessity for treatment was found. In infants of less than 27 weeks' gestation, a significant reduction In the number requiring cryo- or laser therapy was noted (12 of 48 examined [25.0%] vs 6 of 62 examined [9.7%], respectively; P&lt;0.05).<\/jats:p>\n          <jats:p>This decreased need for treatment, however, was found in infants without hyaline membrane disease who did not receive surfactant.<\/jats:p>\n          <jats:p>Conclusion: Exosurf has had no significant impact on the incidence or severity of ROP. Due to its effect on improved survival rates, the surfactant produces a larger proportion of infants at risk of developing ROP. Other changes in NICU protocol may be causing a reduction in the incidence of severe ROP.<\/jats:p>","DOI":"10.3928\/0191-3913-19970901-07","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T22:05:12Z","timestamp":1618956312000},"page":"289-292","source":"Crossref","is-referenced-by-count":20,"title":["Retinopathy of Prematurity in Infants Less Than 29 Weeks' Gestation: 3x\/\u00a3 Years Pre- and Postsurfactant"],"prefix":"10.3928","volume":"34","author":[{"given":"John","family":"Kennedy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A","family":"Todd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Watts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"John","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2308","reference":[{"key":"e_1_3_1_2_1","doi-asserted-by":"crossref","unstructured":"1. Garner A. An international classification of retinopathy of prematurity. ArcA Ophthalmol. 1984;102:1130-1134.","DOI":"10.1001\/archopht.1984.01040030908011"},{"key":"e_1_3_1_3_1","doi-asserted-by":"crossref","unstructured":"2. Keith CG Doyle LW Kitchen WH Murt\u00f3n LJ. Retinopathy of prematurity in infants of 24-30 weeks' gestational age. Med J Aust. 1989;150:293-296.","DOI":"10.5694\/j.1326-5377.1989.tb136487.x"},{"key":"e_1_3_1_4_1","doi-asserted-by":"crossref","unstructured":"3. Todd DA Kennedy J Roberts V John E. Risk factors in progression beyond stage 2 retinopathy of prematurity. Aust NZ J Ophthalmol. 1990;18:57-60.","DOI":"10.1111\/j.1442-9071.1990.tb00585.x"},{"key":"e_1_3_1_5_1","doi-asserted-by":"crossref","unstructured":"4. Todd DA Kennedy J Roberts S et al. Retinopathy of prematurity in infante less than 29 weeks' gestation at birth. Aust NZ J Ophthalmol. 1994;22:19-23.","DOI":"10.1111\/j.1442-9071.1994.tb01690.x"},{"key":"e_1_3_1_6_1","doi-asserted-by":"crossref","unstructured":"5. Todd DA Kennedy J Cassell C et al (For the NSW NICUS study group). Retinopathy of prematurity in infants <29 weeks gestation in NSW from 1986 to 1992. J Paediatr Child Health. 1997; in press.","DOI":"10.1046\/j.1440-1754.1998.00149.x"},{"key":"e_1_3_1_7_1","doi-asserted-by":"crossref","unstructured":"6. Corbet A Bucciarelli R Goldman S et al. American Exosurf study group: decreased mortality rate among small premature infante treated at birth with a single dose of synthetic surfactant: a multicenter trial. JPediatr. 1991;118:277-284.","DOI":"10.1016\/S0022-3476(05)80502-5"},{"key":"e_1_3_1_8_1","doi-asserted-by":"crossref","unstructured":"7. Diwaker K Roberts S John E. Surfactant replacement therapy in neonates less than 32 weeks gestation: effect on neonatal intensive care resource utilization. J Paediatr Child Health. 1993;29:434-437.","DOI":"10.1111\/j.1440-1754.1993.tb03015.x"},{"key":"e_1_3_1_9_1","doi-asserted-by":"crossref","unstructured":"8. Cotton RB Olsson T Law AB et al. The physiologic effects of surfactant treatment on gas exchange in newborn premature infants with hyaline membrane disease. Pediatr Res. 1993;34:495-501.","DOI":"10.1203\/00006450-199310000-00022"},{"key":"e_1_3_1_10_1","doi-asserted-by":"crossref","unstructured":"9. Todd DA Choukroun ML Fayon M et al. Respiratory mechanics before and after late artificial surfactant rescue. J Paediatr Child Health. 1995;31:532-536.","DOI":"10.1111\/j.1440-1754.1995.tb00878.x"},{"key":"e_1_3_1_11_1","doi-asserted-by":"crossref","unstructured":"10. Repka MX Hudak ML Parsa CF Tielsch JM. Calf lung surfactant extract prophylaxis and retinopathy of prematurity. Ophthalmology. 1992;99:531-536.","DOI":"10.1016\/S0161-6420(92)31937-2"},{"key":"e_1_3_1_12_1","doi-asserted-by":"crossref","unstructured":"11. Dunn MS Shennan AT Zayack D Possmayer F. Bovine surfactant replacement therapy in neonates less than 30 weeks' gestation: a randomised controlled trial of prophylaxis versus treatment. Pediatrics. 1991;87:377-386.","DOI":"10.1542\/peds.87.3.377"},{"key":"e_1_3_1_13_1","doi-asserted-by":"crossref","unstructured":"12. Repka MX Hardy RJ Phelps DL Summers CG. Surfactant prophylaxis and retinopathy of prematurity. Arch Ophthalmol. 1993;111:618-620.","DOI":"10.1001\/archopht.1993.01090050052027"},{"key":"e_1_3_1_14_1","doi-asserted-by":"crossref","unstructured":"13. Holmes JM Cronin CM Squires P Myers TF. Randomized clinical trial of surfactant prophylaxis in retinopathy of prematurity. J Pediatr Ophthalmol Strabismus. 1994;31;189-191.","DOI":"10.3928\/0191-3913-19940501-11"},{"key":"e_1_3_1_15_1","doi-asserted-by":"crossref","unstructured":"14. Rankin SJA Tubman TRJ HaUiday HL Johnston SS. Retinopathy of prematurity in surfactant treated infante. Br J Ophthalmol. 1992;76:202-204.","DOI":"10.1136\/bjo.76.4.202"},{"key":"e_1_3_1_16_1","doi-asserted-by":"crossref","unstructured":"15. H\u00f6rbar JD Wright LL Soil RF et al. A multicenter randomized trial comparing two surfactants for treatment of neonatal respiratory distress syndrome. J Pediatr. 1993;123:757-766.","DOI":"10.1016\/S0022-3476(05)80856-X"},{"key":"e_1_3_1_17_1","doi-asserted-by":"crossref","unstructured":"16. Todd DA John E. Evaluation of bubble clicking in gastric aspirate in the newborn. Australian Paediatric Journal. 1983;19:104-106.","DOI":"10.1111\/j.1440-1754.1983.tb02068.x"},{"key":"e_1_3_1_18_1","doi-asserted-by":"crossref","unstructured":"17. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: oneyear outcome-structure and function. ArcA Ophthalmol. 1990;108:1408-1416.","DOI":"10.1001\/archopht.1990.01070120056029"},{"key":"e_1_3_1_19_1","doi-asserted-by":"crossref","unstructured":"18. B\u00fccher H-U Fanconi S Baekert P Duc G. Hyperoxia in newborn infants: detection by pulse oximetry. Pediatrics. 1989;84:226-230.","DOI":"10.1542\/peds.84.2.226"},{"key":"e_1_3_1_20_1","doi-asserted-by":"crossref","unstructured":"19. Thilo EH Anderson D Wasserstein ML et al. Saturation by pulse oximetry: comparison of the results obtained by instruments of different brands. J Pediatr. 1993;122:620-626.","DOI":"10.1016\/S0022-3476(05)83549-8"}],"container-title":["Journal of Pediatric Ophthalmology &amp; Strabismus"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T23:01:44Z","timestamp":1683068504000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/0191-3913-19970901-07"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,9]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1997,9]]}},"alternative-id":["10.3928\/0191-3913-19970901-07"],"URL":"https:\/\/doi.org\/10.3928\/0191-3913-19970901-07","relation":{},"ISSN":["0191-3913","1938-2405"],"issn-type":[{"type":"print","value":"0191-3913"},{"type":"electronic","value":"1938-2405"}],"subject":[],"published":{"date-parts":[[1997,9]]}}}